The chief regulator for medical devices and equipment wants to engage with end-users and their carers to ensure concerns over safety issues are heard more clearly.
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a 12-week consultation on how to best engage and involve patients in its work.
It wants to hear from health and social care and trade professionals as well as end-users and end-user group representatives.
MHRA said it wants to adopt a more systematic approach to listening to and involving patients.
It wants to make sure that the patient voice is more clearly heard when safety issues, concerning medical devices, are identified and in the licensing of new products.
The consultation will additionally look at how patients and the public would like the MHRA to communicate with them.
It will also look at how patients and the public would like to communicate with the MHRA to raise concerns and how the MHRA can best respond.
The consultation, available online, will close on Monday 7 October 2019.
Dr Ian Hudson, CEO of MHRA, said: “It is important that the MHRA continues to evaluate and improve how we can best communicate and engage with patients and the public.
“Patients are at the heart of everything we do and it’s essential that we hear their concerns and opinions to inform our important work protecting public health.
“Every response received will help us gain a better picture of how patients and the public want to engage with the MHRA. We hope to hear from as many people and patient groups as possible.”